+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 50Years
All Genders
Healthy Volunteers
ID06863142

Phase I Study Evaluating Dose, Safety, and Immune Response of Mosaic Hexavalent Influenza Vaccine FluMos-v2 With or Without ALFQ Adjuvant in Healthy Adults

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-23

45

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating an experimental flu vaccine called FluMos-v2, with and without an adjuvant named ALFQ, in healthy adults aged 18 to 50 years. The study aims to test the safety, tolerability, and immune response of these vaccines. Participants must have received at least one flu vaccine from the 2020-21 through the 2024-25 seasons and agree not to receive the licensed 2025-26 flu vaccine during the study. Participants will be divided into groups receiving different doses and combinations of FluMos-v2 and ALFQ. Vaccinations are given as two injections into the upper arm muscle approximately 16 weeks apart. Blood, saliva, and nasal samples will be collected at each visit. An optional procedure called apheresis may be done about two weeks after each vaccination to collect white blood cells. Participants will attend 12 clinic visits over about 15 months, including physical exams, blood tests, and monitoring for flu symptoms. They will record daily symptoms and temperature for a week after each shot. Safety and immune responses will be assessed throughout, including antibody levels and any side effects. The study spans the 2025-26 flu season with follow-up for up to 68 weeks after the first vaccination.

CONDITIONS

Brief Title

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Research Team

V

VRC Clinic

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here